Kilitch Drugs to divest Ethiopian arm for $14 million
The divestment will enable capital reallocation towards higher-growth opportunities in India, debt repayment and expansion of core pharmaceutical business
· 10/24/2026, 5:24:41 AM· 2 min read
The divestment will enable capital reallocation towards higher-growth opportunities in India, debt repayment and expansion of core pharmaceutical business
Read original story →
